Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Peroxiredoxin 1 binding protein and application thereof

A protein-binding technology, applied in the field of medicine and biology, can solve problems such as reducing the incidence of oral cancer, and achieve the effect of improving the expression of binding proteins

Active Publication Date: 2018-12-07
BEIJING STOMATOLOGY HOSPITAL CAPITAL MEDICAL UNIV
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The pathogenesis of oral cancer is a multi-step and multi-stage process. About 70% of oral cancers have definite stages of precancerous lesions. If effective treatment and intervention of oral precancerous lesions and carcinogenesis can greatly reduce the incidence of oral cancer Rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peroxiredoxin 1 binding protein and application thereof
  • Peroxiredoxin 1 binding protein and application thereof
  • Peroxiredoxin 1 binding protein and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1P

[0040] The preliminary identification of embodiment 1Prx1 binding protein

[0041] Co-immunoprecipitation (Co-IP) combined with SDS-PAGE was used to detect the Prx1-binding protein in untreated DOK cells and DOK cells treated with 1 μmol / L nicotine for 7 days. The specific operation was as follows:

[0042] (1) Place a 100mm cell culture dish on ice, wash it once with cold PBS, pour off the PBS, add 1ml of pre-cooled Lysis Buffer, scrape off the cells with a cell scraper, collect the cells, and transfer them to a pre-cooled 2ml centrifuge pipe.

[0043] (2) Add 10 μl of 100× protease inhibitor and phosphatase inhibitor to the cells collected in step 1), place on ice for 40 minutes, and vortex every 10 minutes.

[0044] (3) Centrifuge at 15,300 rpm for 40 min at 4°C, collect the supernatant to obtain soluble whole protein, and place it on ice for later use.

[0045] (4) Prepare the whole cell protein, adjust it to 1 μg / μl, add antibody (Ab) to 500 μl, place on a vortexer at 1...

Embodiment 2

[0053] Example 2 Using bioinformatics methods to analyze Prx1 binding proteins

[0054] The Prx1 binding protein that is detected in embodiment 1 is carried out bioinformatics analysis, mainly comprises GO analysis, kegg pathway analysis, PPI protein interaction network analysis ( Figure 4 ).

[0055] (1) GO analysis is a means to detect the significant function of differential genes based on the gene annotation database. The specific description is as follows.

[0056] ① The genes unique to the nicotine treatment group and genes shared by the two groups were respectively annotated by GO based on the database from three levels of biological process, molecular function, and cellular components.

[0057] ② All the GOs in which the genes participated were obtained by the above operation, and the significance level (P-Value) of each GO was calculated by using the Fisher test, so as to screen out the significant GOs with gene enrichment.

[0058] ③ Significant P-Value<0.05 is ma...

Embodiment 3

[0072] Example 3 Validates the screened Prx1-binding protein

[0073] It mainly includes two aspects: using co-immunoprecipitation (Co-IP) combined with Western Blot method to verify the selected binding protein; using immunohistochemical method to detect the expression of the verified binding protein in mouse tongue tissue from the protein level .

[0074] (1) Use Co-IP combined with Western Blot method to verify the screened binding protein Co-IP experiment is carried out as follows:

[0075] ① Wash the cells twice with pre-cooled PBS, and collect the cells with a scraper.

[0076] ② Add 1ml co-immunoprecipitation lysate (containing PMSF, PIC) and lyse on ice for 15min.

[0077] ③Centrifuge at 4°C, 14 000r / min (centrifugal radius 9.5cm) for 15min, and take the supernatant.

[0078] ④The protein concentration was measured using the Bradford method protein quantification kit, and 25 μg of total protein was retained.

[0079] ⑤ Divide the remaining supernatant equally into Pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a peroxiredoxin 1 binding protein and application thereof, and the peroxiredoxin 1 binding protein comprises one or more of TXN (Trx), ASK1, TPM3, CFL1, GTPBP4, DIRAS2 and PPP2R1A. By immunoprecipitation assay, the peroxiredoxin 1 binding protein can be bonded to peroxiredoxin 1, and nicotine can promote the binding of the peroxiredoxin 1 and the peroxiredoxin 1 binding protein. In oral precancerous lesions such as leukoplakia cells, the expression of the peroxiredoxin 1 binding protein is significantly increased, and the nicotine can regulate the expression of the theperoxiredoxin 1 binding protein. The peroxiredoxin 1 binding protein can be used as a molecular marker for diagnosing or preventing the oral precancerous lesions such as oral leukoplakia, preparing aPrx1 protein conjugate, or binding, labeling, identifying, enriching, sorting or purifying Prx1 overexpresses cells.

Description

technical field [0001] The invention belongs to the technical field of medicine and biology, and in particular relates to a peroxide reductase 1 binding protein and an application thereof. Background technique [0002] The incidence of oral cancer ranks sixth among all tumors in the whole body. Every year, there are about 650,000 new cases of oral cancer and 350,000 deaths worldwide. my country is one of the countries with high incidence and high mortality of oral cancer. Although the treatment methods have been continuously improved in the past 30 years, the average 5-year survival rate has always hovered around 50%, which has not been significantly improved, which seriously threatens people's life, health and survival. quality. The pathogenesis of oral cancer is a multi-step and multi-stage process. About 70% of oral cancers have definite stages of precancerous lesions. If effective treatment and intervention of oral precancerous lesions and carcinogenesis can greatly redu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/02C12N9/12C12N9/16C12N15/53C12N15/54C12N15/55C07K14/47C12N15/12C12Q1/6886C12Q1/6883A61K45/00A61P35/00A61P1/02
CPCA61K45/00A61P1/02A61P35/00C07K14/47C07K14/4716C12N9/001C12N9/0051C12N9/12C12N9/16C12Q1/6883C12Q1/6886C12Q2600/156C12Y108/01008C12Y207/11025
Inventor 汤晓飞齐墨词张敏陈慧李玲玉王敏葛丽华杨晶
Owner BEIJING STOMATOLOGY HOSPITAL CAPITAL MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com